바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.59 No.2
Citation Share

Pulmonary Resection Combined with Isoniazid-and Rifampin-based Drug Therapy for Patients with Multidrug-resistant Tuberculosis

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2005, v.59 no.2, pp.179-185



& (2005). Pulmonary Resection Combined with Isoniazid-and Rifampin-based Drug Therapy for Patients with Multidrug-resistant Tuberculosis. Tuberculosis & Respiratory Diseases, 59(2), 179-185.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background : To evaluate the clinical efficacy of pulmonary resection combined with first-line antituberculous drug therapy in patients with well-localized, cavities-containing pulmonary multidrug-resistant tuberculosis (MDR-TB). Method : From February 1998, seventeen patients with well-localized, cavities-containing pulmonary MDR-TB were enrolled and followed prospectively up to December 2004. After radical pulmonary resection, the patients were treated with antituberculous drugs comprising of isoniazid (H), rifampin (R), pyrazinamide (Z), ethambutol (E), and streptomycin (S) (3HERZS/3HERS/6HER). Results : All recovered isolates of M. tuberculosis were resistant to both isoniazid and rifampin, and to a mean of 4.8 antituberculous drugs (range, 2 to 7 drugs). Surgical procedures included lobectomy (13 patients), lobectomy plus segmentectomy (3 patients), and pneumonectomy (1 patient). The median time for postoperative sputum smear and culture conversion was 2 days (range, 1 to 23 days). Fifteen (94%) patients had durable cures (mean follow-up period, 39.0 months). One patient failed to convert her sputum and was successfully switched to second-line therapy; one patient developed active disease again almost 7 years later, likely due to re-infection with a new M. tuberculosis strain.  Conclusion : Radical resection combined with administration of first-line antituberculous agents was effective in patients with well-localized, cavities-containing pulmonary MDR-TB. (Tuberc Respir Dis 2005; 59: 179-185)

keywords
Pulmonary tuberculosis, MDR-TB, Lung surgery, Pulmonary tuberculosis, MDR-TB, Lung surgery

Reference

1.

Iseman MD, (1993) Treatment of multidrug-resistant tuberculosis,

2.

Report on the 7th tuberculosis prevalence survey in Korea, (1996) Ministry of Health and Welfare, Korean National Tuberculosis Association

3.

Dye C, (2002) Worldwide incidence of multidrug-resistant tuberculosis,

4.

Park SK, (1997) Clinical study of pulmonary tuberculosis for admitted patients at National Masan Tuberculosis Hospital,

5.

Park SK, (2005) Clinical observational study of pulmonary tuberculosis for admitted patients at a National Tuberculosis Hospital:comparison with the previous results in 1995,

6.

Canetti G, (1961) Percentage of isoniazid-resistant and streptomycin-resistant variants in wild strains of Mycobacterium tuberculosis on Loewenstein-Jensen medium,

7.

Iseman MD, (1990) Surgical intervention of pulmonary disease caused by drug-resistant Mycobacterium tuberuclosis,

8.

van Leuven M, (1997) Pulmonary resection as an adjunct in the treatment of multiple drug-resistant tuberculosis,

9.

Pomerantz M, (1997) Surgery in the treatment of multidrug-resistant tuberculosis, Clin Chest Med

10.

Sung SW, (1999) Surgical management of multidrug resistant pulmonary tuberculosis,

11.

Kwon ES, (1998) Pulmonary resection in the treatment of multidrug-resistant tuberculosis,

12.

Park SK, (2002) A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis,

13.

Sim YS, (1998) Update in refractory pulmonary tuberculosis,

14.

Park SK, (1996) Clinical course of cavitary lesions in pulmonary tuberculosis,

15.

Jun HJ, (1997) Clinical evaluation of surgical resection of surgical resection on pulmonary tuberculosis:multiple drug resistant tuberculosis,

16.

Pomerantz M, (1995) The surgical management of tuberculosis,

17.

Sim SB, (1992) Clinical evaluation of posititve sputum AFB cases following pulmonary resection of pulmonary tuberculosis,

18.

van Rie A, (1999) Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment,

19.

Kim AJ, (1996) Surgical treatment of pulmonary tuberculosis,

20.

Pomerantz M, Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections,

21.

Kaplan G, (2003) Mycobacterium tuberculosis growth at the cavity surface:a microenvironment with failed immunity,

22.

Post FA, (2004) Genetic polymorphisms in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis,

23.

Song W, (2003) In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa,

24.

Yoon J, (2004) In vitro double and triple synergistic activities of polymyxin B,imipenem,and rifampin against multidrug-resistant Acinetobacter baumannii,

25.

Fish DN, (2002) Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs,

26.

Urban C, (2003) Considerations in control and treatment of nosocomial infections due to multidrugresistant Acinetobacter baumannii,

Tuberculosis & Respiratory Diseases

e-Submission OA Policy